Breaking News

POINT Biopharma to Launch First US Manufacturing Facility

Next-gen oncology company plans long-term manufacturing growth, 100+ high-wage jobs in Indianapolis

By: Contract Pharma

Contract Pharma Staff

POINT Biopharma, a global, clinical-stage pharmaceutical company specializing in the development and production of radiopharmaceuticals for cancer treatments, has unveiled plans to establish its first U.S. manufacturing facility in Indianapolis, IN. To support its growth, the company plans to create more than 100 new, high-wage jobs by the end of 2024.   “Indiana has established itself as a global leader in life sciences, ranking second in the nation for total exports,” Governor Eric J. Ho...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters